Modifies provisions relating to epinephrine products

HB 553 allows students with asthma or severe allergic reactions (anaphylaxis) to self-administer prescribed epinephrine auto-injectors or nasal spray at school under specific conditions. Schools must permit this if a doctor approves the medication, the student demonstrates proper use, parents sign a liability form, and a written treatment plan is provided. The bill also requires schools to maintain emergency epinephrine supplies accessible to staff and ensures trained school personnel can administer it during life-threatening reactions without liability for non-negligent actions. This replaces vague prior rules with clear protocols for student safety and school responsibility.